Dialog Box


Lenalidomide (RevlimidR)

What is Revlimid used for?

Lenalidomide is an immunotherapy medicine that works by activating the body’s immune system to target and kill the lymphoma cells. The medicine helps prevent the lymphoma cells from growing by cutting off their blood supply that they require to exist.

Lenalidomide is structurally related to thalidomide and is used for a number of haematological malignancies including multiple myeloma, myelodysplastic syndrome and clinical trials have been working with those with CLL/SLL and outlook for other subtypes of lymphoma in the future.

Lenalidomide (RevlimidR) is now indicated for the treatment of:

  • Patients with relapsed and/or refractory mantle cell lymphoma (MCL).
  • MCL as a second line treatment
 Lenalidomide may have the following side effects:

  • Fatigue
  • Diarrhoea
  • Constipation
  • Fever
  • Itching
  • Rash
  • Lowered blood counts
  • Nausea
  • Swelling of the limbs and skin
  • Atrial fibrillation
  • Depression
  • Insomnia

Note: Pregnancy needs to be prevented while taking medication


Further details:

Product Information

Consumer Information  

For further information contact Celgene http://www.celgene.com.au/